NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OncoGenesis, Inc.

OncoGenesis, Inc.

Private
Salinas, CaliforniaHealthcare & Life Scienceshttps://oncogenx.com/

Last Round

VC Round

Jul 1, 2019

Total Funding Raised

$8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OncoGenesis, Inc. is a medical technology company that develops diagnostic systems and self-collection devices for cervical cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

image-guided superficial radiotherapyIG-SRTnon-melanoma skin cancernon-surgical skin cancer treatmentdermatology medical deviceradiation oncologyskin cancer radiotherapynon-invasive cancer therapyGentleCureradiation therapyskin cancer surgery alternativemedical equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoGenesis, Inc. Comparables

Compare OncoGenesis, Inc. with similar companies based on industry and business-model similarity.

OncoGenesis, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aindra Systems
35%
Hera Biotech
35%
Teal Health
34%

OncoGenesis, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2019
SeedSep 1, 2018

Key People

Founding team and executive leadership

Paul Vichi

Co-Founder, Chief Technology Officer & SVP

Founding Team

OncoGenesis, Inc. Investors

Notable investors and investment history

OncoGenesis, Inc. investors
InvestorRounds
US Capital Global SecuritiesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 145% MoM, reaching 4.6K.

OncoGenesis, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoGenesis, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoGenesis, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSalinas, California
Employee Range7
Year Founded2008
Last FundingJul 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.